TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (CSE: ZRO) is pleased to announce, in conjunction with Microbial Research Products, the Joint Venture (JV) Agreement announced on February 28, 2018, it has signed its first Royalty Agreement for its Tri-Filler patented technology with Polski Bazalt / STM Technology (STM).
This five year exclusive arrangement will give STM worldwide rights for its basalt composite products. STM is forecasting to start using the product towards end of the year. All other terms and conditions are confidential.
The Chairman and CEO of Biosenta, Dene Rogers, and the Chairman of the JV partner, Bill Connor, said “We are proud to have partnered with STM to develop Tri-Filler for their unique composite basalt products. The signing of this agreement is a significant step forward for the JV and the result of the efforts of many people”.
Biosenta is continuing to discuss additional licensing agreements of its patented products.
About Biosenta Inc.
Biosenta Inc. develops and manufactures a range of chemical compounds for household and industrial applications using advanced encapsulated nanotechnology.
Other household disinfectants and cleaners possess similar levels of efficacy as traditional disinfectants. But Biosenta products contain significantly lower concentrations of active ingredients resulting in lower toxicity.
Biosenta disinfectants and cleaners will kill 99.9% of potentially deadly mold, fungi, bacteria and viruses on contact and prevent re-growth. Biosenta disinfectants are very safe due to the very low toxicity.
Biosenta industrial compounds are embedded to protect various materials, including drywall, plastic and resins, from microbe formation.
These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, and carpet rubber backing and synthetic tufts which contain plastic or resin, as well as textiles and paper from mold, fungi, bacteria and viruses. Both the Biosenta household and industrial products are environmentally safe and biodegradable.
Disclaimer
The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information contact:
Dene Rogers, President and CEO
Biosenta Inc.
18 Wynford Drive, Suite 704
Toronto, ON M3C 3S2
Phone: 416-410-2019
Email: dene@biosenta.com
info@biosenta.com